evidenceId,evidenceType,shortDesc,desc,id,lastEdit,status,gene/entrezGeneId,gene/hugoSymbol,gene/name,gene/oncogene,gene/curatedIsoform,gene/curatedRefSeq,gene/geneAliases/0,gene/geneAliases/1,gene/geneAliases/2,gene/geneAliases/3,gene/tsg,articles/0/pmid,articles/0/title,articles/0/journal,articles/0/pubDate,articles/0/volume,articles/0/issue,articles/0/pages,articles/0/authors,articles/0/elocationId,articles/0/link,articles/0/reference,articles/0/abstract,articles/1/pmid,articles/1/title,articles/1/journal,articles/1/pubDate,articles/1/volume,articles/1/issue,articles/1/pages,articles/1/authors,articles/1/elocationId,articles/1/link,articles/1/reference,articles/1/abstract,articles/2/pmid,articles/2/title,articles/2/journal,articles/2/pubDate,articles/2/volume,articles/2/issue,articles/2/pages,articles/2/authors,articles/2/elocationId,articles/2/link,articles/2/reference,articles/2/abstract,articles/3/pmid,articles/3/title,articles/3/journal,articles/3/pubDate,articles/3/volume,articles/3/issue,articles/3/pages,articles/3/authors,articles/3/elocationId,articles/3/link,articles/3/reference,articles/3/abstract,articles/4/pmid,articles/4/title,articles/4/journal,articles/4/pubDate,articles/4/volume,articles/4/issue,articles/4/pages,articles/4/authors,articles/4/elocationId,articles/4/link,articles/4/reference,articles/4/abstract,articles/5/pmid,articles/5/title,articles/5/journal,articles/5/pubDate,articles/5/volume,articles/5/issue,articles/5/pages,articles/5/authors,articles/5/elocationId,articles/5/link,articles/5/reference,articles/5/abstract
7738,GENE_BACKGROUND,,"The CBL gene encodes a proto-oncogene and E3 ubiquitin-ligase involved in the degradation of receptor tyrosine kinases (PMID: 11283727, 23085373). The CBL protein has several evolutionary conserved regions, including a tyrosine kinase binding domain, a zinc-finger binding RING domain and a short linker sequence connecting the tyrosine kinase binding and RING domains (PMID: 11283727). Together, these regions form a structure for binding to an E2 ubiquitin conjugating enzyme, which is essential for the E3 activity of CBL (PMID: 23085373). CBL family E3 ligases selectively and negatively regulate activated receptor tyrosine kinases, including EGFR (PMID: 23085373), PDGFR (PMID: 11283727), CSF-1R (PMID: 11283727), MET (PMID: 24384534), FLT3 (PMID: 17446348), through ubiquitylation that targets these proteins for degradation by the proteosome (PMID: 11283727). In addition to receptor tyrosine kinase regulation, CBL-b is also involved in T cell activation and peripheral T cell tolerance (PMID: 24875217, 17704644, 11283727).",,2017-04-27,,867,CBL,Cbl proto-oncogene,False,ENST00000264033,NM_005188.3,NSLL,RNF55,C-CBL,CBL2,True,17704644,The ubiquitin E3 ligase Cbl-b in T cells tolerance and tumor immunity.,"Cell cycle (Georgetown, Tex.)",2018-10-15T20:07:00,6,20,2478-85,Loeser S et al,,,0001-10-15,,23085373,Protein tyrosine kinase regulation by ubiquitination: critical roles of Cbl-family ubiquitin ligases.,Biochimica et biophysica acta,2018-01-01T20:13:00,1833,True,122-39,Mohapatra B et al,doi: 10.1016/j.bbamcr.2012.10.010,,0001-01-01,,24875217,E3 ubiquitin ligase Cbl-b in innate and adaptive immunity.,"Cell cycle (Georgetown, Tex.)",2014,13,12,1875-84,Liu Q et al,doi: 10.4161/cc.29213,,"Liu Q et al. Cell cycle (Georgetown, Tex.). 2014;13(12)1875-84.",,24384534,The Met receptor tyrosine kinase: a key player in oncogenesis and drug resistance.,Pharmacology &amp; therapeutics,2018-06-01T20:14:00,142,3,316-38,Maroun CR et al,doi: 10.1016/j.pharmthera.2013.12.014,,0001-06-01,,11283727,Cbl: many adaptations to regulate protein tyrosine kinases.,Nature reviews. Molecular cell biology,2018-04-01T20:01:00,2,4,294-307,Thien CB et al,,,2018-04-01T03:07:00,,17446348,Flt3-dependent transformation by inactivating c-Cbl mutations in AML.,Blood,2018-08-01T20:07:00,110,3,1004-12,Sargin B et al,,,0001-08-01,
7737,GENE_SUMMARY,,CBL encodes an E3 ubiquitin ligase that negatively regulates receptor tyrosine kinases.,,2017-04-27,,867,CBL,Cbl proto-oncogene,False,ENST00000264033,NM_005188.3,NSLL,RNF55,C-CBL,CBL2,True,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
